Xenetic Biosciences Announces Positive Phase 1 Clinical Data for PulmoXen(TM) for Treatment of Cystic Fibrosis Apr 7, 2014
Xenetic Biosciences Announces Opening of Corporate Headquarters and R&D Facility in Lexington, MA Mar 4, 2014
